Dr Robert Tansley joins Serentis
This article was originally published in Scrip
Executive Summary
Dr Robert Tansley has joined the UK biopharmaceutical company Serentis as chief medical officer. He was previously development and medical director of Sosei R&D. Dr Tansley has also held roles in development and regulatory affairs at Sanofi, Roche, Arakis and as a medical assessor in the licensing division of the Medicines and Healthcare products Regulatory Agency (MHRA).